Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists

Abstract

These findings suggest that MBS was associated with more weight loss at lower ongoing costs compared with GLP-1 RAs in class II and III obesity. Further study is needed to determine if MBS should still be considered the last resort in treating obesity.